These success, together with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 assistance the idea of focusing on ACKR3 as a unique method to modulate the opioid process, which could open up new therapeutic avenues for opioid-associated disorders. By ticking this box https://johnnieb814hfc5.life3dblog.com/profile